Persistent high blood pressure, or resistant hypertension, requires a proactive and personalized approach beyond just ...

High blood pressure, often symptomless, poses significant health risks if untreated, warns Dr. Praneeth Suryadevara. Early ...

The latest clinical win follows a dual set of phase 3 and phase 2 results back in March. In that data drop, Mineralys reported that lorundrostat reduced systolic blood pressure in a late-stage study ...

A new study led by researchers at University of Iowa Health Care has revealed a significant association between high blood ...

In a news release, the university said the findings suggest inflammation in the brain could play a role in the relationship ...

High blood pressure during pregnancy increases the risk of seizures in children, warns new research. A "significant ...

Browns Mills, N.J.-based Deborah Heart and Lung Center named Geurys Rojas-Marte, MD, medical director of advanced heart failure and pulmonary hypertension programs, the hospital said in a June 14 ...

The DASH (Dietary Approaches to Stop Hypertension) diet effectively treated high blood pressure among type 2 diabetics, ...

The researchers hypothesized that sildenafil would increase oxygen flow to the placenta and to the unborn fetus, reducing ...

A new study led by researchers at University of Iowa Health Care has revealed a significant association between high blood ...

Alcohol can harm your heart, depending on how much you drink. Excess consumption can increase your risk of heart disease.

Investing.com -- Mineralys Therapeutics Inc (NASDAQ: MLYS) stock surged 7.9% after reporting positive topline data from its Phase 2 Explore-CKD trial for lorundrostat in patients with hypertension and ...